ScreenerHero

LFWD Lifeward Ltd.

NAS · US · Healthcare · Medical Devices · golifeward.com
6.500USD+2.52%Mkt Cap: 18.41M $P/E: —

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in …

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$171.97BUSDP/E 31.8
MDT
Medtronic plc
$109.38BUSDP/E 21.0
SYK
Stryker Corporation
$105.64BUSDP/E 28.5
BSX
Boston Scientific Corporation
$60.26BUSDP/E 16.8
EW
Edwards Lifesciences Corporation
$49.39BUSDP/E 51.1
SHL
Siemens Healthineers AG
$46.91BUSDP/E 19.6
DXCM
DexCom, Inc.
$31.81BUSDP/E 33.5
GEHC
GE HealthCare Technologies Inc.
$29.42BUSDP/E 14.9
PHIA
Koninklijke Philips N.V.
$22.87BUSDP/E 18.7
PHG
Koninklijke Philips N.V.
$23.55BUSDP/E 18.0
STE
STERIS plc
$20.44BUSDP/E 25.6
SOON
Sonova Holding AG
$17.11BUSDP/E 28.0
ZBH
Zimmer Biomet Holdings, Inc.
$16.88BUSDP/E 21.5
PEN
Penumbra, Inc.
$12.46BUSDP/E 77.7
SNN
Smith & Nephew plc
$11.25BUSDP/E 18.3
DEMANT
Demant A/S
$9.87BUSDP/E 28.0
GKOS
Glaukos Corporation
$10.16BUSD
TXG
10x Genomics, Inc.
$9.92BUSD
GMED
Globus Medical, Inc.
$9.90BUSDP/E 18.9
BIO
Bio-Rad Laboratories, Inc.
$9.85BUSDP/E 46.6
HeadlineSourceTime
Older
Lifeward (LFWD) Reports Q2 Loss, Misses Revenue Estimates

Lifeward (LFWD) delivered earnings and revenue surprises of +2.01% and -10.74%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Ovid Therapeutics (OVID) Reports Q2 Loss, Beats Revenue Estimates

Ovid Therapeutics (OVID) delivered earnings and revenue surprises of +20.00% and +388.67%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Natera (NTRA) Reports Q2 Loss, Beats Revenue Estimates

Natera (NTRA) delivered earnings and revenue surprises of 0.00% and +14.23%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks